FDA Investigator William C Brenneman
William C Brenneman has conducted inspections on 308 sites in 1 countries as of 02 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
308
Last Inspection Date:
02 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with William C Brenneman:
Abdellah El Hajjam,
Alan D Centi,
Amy N Chen,
Anastasia M Shields,
Angela L Hatzenbuhler,
Anita R Michael,
Ann Marie Karnick,
Anthony R Rauert,
Audrey Thereset Uy,
Brandi L Garbutt,
Brandon J Brookens,
Brian D Young,
Brian S Keefer,
Calvin W Edwards,
Cara M Minelli,
Carl E Lovrich,
Caryn M Mcnab,
CDR Michael J Mero,
Chamberlain,
Christopher Bastedo,
Chyla T Hunter,
Crayton Lee,
Crystal A Harlan,
Cynthia White,
Daniel R Tammariello,
Daniel W Johnson,
Darlene C Plank Turlington,
Dauksism,
David A Schwartz,
David J Hafner,
David L Pearce,
Deborah G Haney Cozzone,
Deborah H Cozzone,
Debra J Bennett,
Dennis R Hock,
Derek S Dealy,
Deyaa Shaheen,
Dr. Mark J Seaton, PhD,
Edward D Mcdonald,
Eric Rothschild,
Eric S Myskowski,
Erika M Wilkerson,
Gayle S Lawson,
Gerald W Kopp,
Gillian B Nardelli,
Gregory E Beichner,
Jacqueline Johnson,
Jacquelyn Gess,
James M Mason,
James P Mcevoy,
Jason M Sluzynski,
Jeannie R Mayberry,
Jeen S Min,
Jessica D Weber,
Jessica M Monteiro,
Joseph R Hatcher,
Joseph T Dougherty,
Joshua C Schafer,
Judith A Paterson,
Julianne C Mccullough,
Katelyn Astaub Zamperini,
Kelly N Kerr,
Kimberly A Dux,
Kirk A Dymbrowski,
Kristina J Donohue,
Kyle D Covill,
Kyle S Hobson,
LCDR Margaret Edi Gennaro,
LCDR Susan E Polifko,
LCDR William H Bender,
Linda M Sacco,
LT John M Mastalski,
LTJG Bradley E Benasutti,
LTJG Lauren N Shade,
Marjorie L Davis,
Mary E Storch,
Mary R Kirker,
Matthew R Noonan,
Maureen A Duckworth,
Maureen A Wentzel,
Melissa M Dauksis,
Melissa M Schafer,
Michael A Taylor,
Michele M Falchek,
Myrick,
Nicole J Clausen,
Nikisha M Bolden,
O'meara,
Princess R Campbell,
Rahi D Patel,
Raymond L Cheung,
Ronald T Colucci,
Sean D Duke,
Sena G Dissmeyer,
Stephanie Mangigian, MS/OSH, RN,
Steven J Libal,
Susan F Laska, MS,
Tammy M Phillips,
Thomas N Adjabeng,
Timothy J Schmidt,
Todd J Maushart,
Tonilynn Coiley,
Travis R Hunt,
Van Cliff,
Vlada Matusovsky,
Whitney S Reynolds,
William A Warnick
William C Brenneman's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more